TROG HOME
The Trans-Tasman Radiation Oncology Group (TROG) is Australia and New Zealand's specialist clinical research group for cancers that can be treated with radiotherapy. TROG is a cooperative multi-disciplinary organisation dedicated to the control of a wide range of cancers through quality multi-centre research.
TROG provides the infrastructure and governance for national and international collaborations to help ensure the development of more effective treatments for cancer. Currently over 300 clinicians and other researchers and over 7000 patients have contributed to the TROG research program.
Through these collaborative efforts, involving over 40 cancer treatment centres across Australia and New Zealand, as well as contributing centres internationally, TROG has launched over 50 clinical research studies and achieved significant improvements in patient care and outcomes.